Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Capital Reinvestment Ratio
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd capital reinvestment ratio. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥43.77 Million) in capital expenditures (CN¥3.65 Million). Check Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2009–2025)
Capital reinvestment ratio of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2009 to 2025. This chart tracks Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Also explore Shanghai Fudan-Zhangjiang Bio-Pharmaceut equity growth rate to track the company's year-over-year net asset growth rate.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2009–2025)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥141.40 Million | CN¥32.37 Million | ▼ -83.6% |
| 2023 | 1.39x | CN¥71.02 Million | CN¥98.97 Million | ▲ +163.8% |
| 2022 | 0.53x | CN¥165.27 Million | CN¥87.30 Million | ▲ +18.3% |
| 2021 | 0.45x | CN¥268.90 Million | CN¥120.12 Million | ▲ +19.0% |
| 2020 | 0.38x | CN¥113.00 Million | CN¥42.41 Million | ▲ +150.2% |
| 2019 | 0.15x | CN¥269.23 Million | CN¥40.39 Million | ▼ -31.0% |
| 2018 | 0.22x | CN¥173.94 Million | CN¥37.79 Million | ▼ -84.8% |
| 2017 | 1.43x | CN¥42.71 Million | CN¥60.94 Million | ▲ +328.4% |
| 2016 | 0.33x | CN¥140.57 Million | CN¥46.82 Million | ▼ -19.3% |
| 2015 | 0.41x | CN¥96.30 Million | CN¥39.75 Million | ▼ -18.8% |
| 2014 | 0.51x | CN¥88.36 Million | CN¥44.91 Million | ▼ -20.8% |
| 2013 | 0.64x | CN¥89.44 Million | CN¥57.38 Million | ▼ -38.4% |
| 2012 | 1.04x | CN¥110.19 Million | CN¥114.69 Million | ▲ +56.5% |
| 2011 | 0.67x | CN¥49.59 Million | CN¥32.99 Million | ▼ -90.8% |
| 2009 | 7.23x | CN¥7.72 Million | CN¥55.82 Million | — |